PFIC is a group of rare inherited liver conditions that affects the body's ability to transport and circulate bile, which is essential for digesting and absorbing fats, as well as removing waste ...
In medicine discovery, identifying the right biological target has always been a critical and complex step. Today, the rise of powerful screening tools is fundamentally reshaping this process, ...
PARIS, FRANCE, 19 December 2025 – Ipsen (Euronext: IPN; ADR: IPSEY) today announced that the pivotal Phase II FALKON trial did not meet its primary endpoint of reducing new heterotopic ossification ...
As a result, PFIC is often overlooked, dismissed or attributed to other causes, 6,13 which can leave people feeling frustrated and unsupported. Indeed, many adults with PFIC spend years, or even ...
A study to compare how the body absorbs different capsule strengths of fidrisertib and how food changes this process in healthy adults ...
A study to assess the effects of fidrisertib on the amount of caffeine and a combined oral contraceptive in the blood of healthy adults ...
We are living in an era of extraordinary scientific progress. We can target diseases in ways that were unimaginable a generation ago, develop increasingly sophisticated medicines and explore entirely ...
They work at Ipsen, but their job titles tell only part of who they are. We asked them to share the experiences that have shaped their lives and perspectives, and to tell us more about who they are ...
To request medical information on Ipsen’s products, report an adverse event or report a complaint, please visit: Ipsen Medical Information or email us at globalmedinfo@ipsen.com Adverse event ...
At Ipsen, we work together to create real impact every day, for our patients and society. With a global footprint and 90+ year history, we have what it takes to make an impact on patients and society.
Progressive Familial Intrahepatic Cholestasis (PFIC) can be a complex condition. Finding trusted information about PFIC shouldn’t be. PFIC Colors is ...
PARIS, France, 5 November 2019 – The Board of Directors of Ipsen (Euronext: IPN; ADR: IPSEY) takes note of the proposed demerger of Mayroy and the internal reclassification of its Ipsen shares, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results